In laboratory preclinical studies, these drugs help reduce harmful protein clumps in the brain
Because IV therapy lacks FDA approval for skin lightening, and the long-term effects remain unknown, it is crucial to weigh the effectiveness against these potential side effects
Front Endocrinol (Lausanne) (2022) 13:800714
Examples of laminopathies include EmeryDreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy type 1B (LGMD1B) has been reclassified as EDMD2, congenital muscular dystrophy (CMD), dilated cardiomyopathy type 1A, familial partial lipodystrophy type 2, and early aging syndromes such as HutchinsonGilford progeria syndrome 5
Vitamin B12 or folate deficiency anaemia - Causes
A New Class of GLP-1 Drugs & What They Might Mean for Skin According to a press release, researchers are developing a next-generation weight-loss drug that works on four different hormones at once GLP-1, GIP, glucagon, and peptide YY